Analyst price target range
iBio Price Target: $5.69 Average
Direct answer
iBio's average price target is $5.69.
The verified analyst range runs from $4.20 to $7.00.
The low target implies +228.1%, the high target implies +446.9%, and the range spans 218.8% of the current price.
Forecast evidence checked September 21, 2026.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.28
- Average price target
- $5.69
- High price target
- $7.00
- Low price target
- $4.20
- Low target gap
- +228.1%
- Target upside
- +344.4%
- High target gap
- +446.9%
- Target range width
- 218.8%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- September 21, 2026
- Valid through
- September 28, 2026
Explore related company data
Read the frequently asked questions.
What is iBio's average price target?
iBio's verified average price target is $5.69. The target range is $4.20 to $7.00.
How far are iBio's low and high targets from the recorded price?
The low target implies +228.1%, while the high target implies +446.9%.
How many analysts are included in iBio's consensus?
The verified consensus includes 9 analysts.
How is iBio's target upside or downside calculated?
The average target of $5.69 is divided by the recorded price of $1.28, then one is subtracted to produce +344.4%. This does not guarantee a future return.
When was iBio's analyst forecast verified?
The data was verified on 2026-09-21. The dataset is valid through 2026-09-28.